Aside from the expected expansions of thymic-derived FOXP3+HELIOS+ Tregs and CD56br NK cells in T1D patients, we show that iLD-IL-2 reduces the frequency of IL-21-producing CD4+ T cells. This evidence concerns the gene IL21 and type 1 diabetes mellitus.